Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atypical Hyperplasia of the Breast”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableStudy completedNCT00146536
What this trial is testing

Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy

Who this might be right for
Breast Neoplasms
Dana-Farber Cancer Institute 78
Not applicableActive Not RecruitingNCT04496739
What this trial is testing

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

Who this might be right for
Atypical Hyperplasia of the BreastLobular Breast Carcinoma In SituPleomorphic Lobular Breast Carcinoma In Situ
SWOG Cancer Research Network 412
Not applicableLooking for participantsNCT05178498
What this trial is testing

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+2 more
Ohio State University Comprehensive Cancer Center 960
Not applicableStudy completedNCT00339248
What this trial is testing

Markers for Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 2,632
Not applicableWithdrawnNCT03868475
What this trial is testing

Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions

Who this might be right for
Breast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Testing effectiveness (Phase 2)Looking for participantsNCT06195306
What this trial is testing

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT01925586
What this trial is testing

Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)

Who this might be right for
Atypical Ductal Hyperplasia (ADH) of the Breast
Yale University 9
Testing effectiveness (Phase 2)Study completedNCT00291135
What this trial is testing

Protocol for Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 42
Testing effectiveness (Phase 2)Study completedNCT00291694
What this trial is testing

Protocol for Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 72
Testing effectiveness (Phase 2)Ended earlyNCT04570956
What this trial is testing

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Who this might be right for
Breast Atypical HyperplasiaBreast Lobular Carcinoma in SituBreast Atypical Lobular Hyperplasia+1 more
Mayo Clinic 65
Not applicableUnknownNCT05932758
What this trial is testing

Excisional Vacuum-Assisted Breast Biopsy

Who this might be right for
Atypical Ductal HyperplasiaDuctal Carcinoma in Situ
European Institute of Oncology 300
Not applicableNot Yet RecruitingNCT07245316
What this trial is testing

Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial

Who this might be right for
Ductal Carcinoma in Situ of the Breast
Jeong Eon Lee 340
Not applicableUnknownNCT01034891
What this trial is testing

Women At Risk: The High Risk Breast Cancer Program

Who this might be right for
Breast Cancer
New York Presbyterian Hospital 2,000
Not applicableEnded earlyNCT00794989
What this trial is testing

Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
Roswell Park Cancer Institute 20
Not applicableUnknownNCT05868252
What this trial is testing

Molecular Analysis of the Sloane Project

Who this might be right for
DCISLCISAtypical Ductal Hyperplasia+1 more
King's College London 1,500
Not applicableStudy completedNCT00666731
What this trial is testing

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
University of Nebraska 4,945
Testing effectiveness (Phase 2)Looking for participantsNCT05941520
What this trial is testing

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 80